Gap junctions or hemichannels are expressed on all cells in our body, and have a highly significant role in homeostasis and in disease states. There are 21 connexins found in humans and they have distinct characteristics that compensate for each other. The anatomical expression pattern also differs between each connexin; some of them are expressed together and some are not. Genetically mutated connexin genes induce inheritable diseases, but acquired disorders can also be caused by primary or secondary connexin dysfunctions. In the central nervous system, glial cells are the main connexin-expressing cells. They utilize connexin gap junctions to assemble glial networks. The present review not only describes the basic structures and functions of connexins, it also examines the relationships between connexins and their role in disease pathology.
Introduction
Gap junctions are specialized intercellular connections that directly connect cytoplasm between different cells. They are also called electrical synapses when found in neurons. Gap junctions allow various molecules, ions and electrical impulses to pass through and in between cells. Gap junctions in vertebrates are composed of connexins. Connexins are known to have various physiological and pathological functions, and knowledge of the importance of connexins is gradually increasing, as the numbers of publications indicates (Fig. 1 ). The present review will focus on various functions of connexins in health and disease, mainly in the central nervous system (CNS).
Structures and functions of connexins
Molecules that comprise gap junctions are called connexins. Connexins contain four transmembrane segments (M1-M4), unstructured C and N terminals, one cytoplasmic loop, and two extracellular loops (E1, E2; Fig. 2 ). While the transmembrane domains and extracellular loops are highly conserved among the family members, the cytoplasmic loop and the C-terminus show great variation in terms of sequence and length. 1 There are 21 connexins with different molecular weights in humans and 20 connexins in mice. Among them, 19 connexins are common. Naming of each connexin depends on its molecular weight (e.g. connexin 43 is the connexin of 43 kDa). Other nomenclature based on their type of structure (gap junction [GJ] A, GJB etc.) is also common and has been officially agreed to. Connexins are expressed by nearly all cells in the human body. Expression of connexin subtypes is restricted and depends on anatomical location (Table 1) . 2 Each connexin peptide assembles hemichannels in groups of six homotypic or heterotypic combinations, named connexons (hemichannels). Connexin proteins are assembled into connexons and they are inserted into the cell membrane. Two connexons form gap junctions between cells by a head-to-head configuration, again with a homotypic or heterotypic combination, but some connexons also work as hemichannels (Fig. 2) . Pannexins, which are another form of cell surface channel, always work as hemichannels. Each combination of connexins has different functional properties for pore conductance, charge selectivity, voltage gating and chemical gating. Hemichannels can affect cellular homeostatic processes by enabling the passage of signaling molecules between the intracellular and extracellular space. The controlled opening of hemichannels and gating properties of complete gap junctions can be regulated through post-translational modifications of connexins. A recent study showed that connexins can be modified by phosphorylation/dephosphorylation, redox-related changes, acetylation, methylation or ubiquitination. 3 For example, connexin (Cx) 43 has 21 reported phosphorylation sites, and each site differentially controls gating and selectivity properties. 4 In addition, these phosphorylation sites are located on the cytoplasmic C-tail and loop that characterize each connexin (Fig. 2) .
Permeability of gap junctions has long been thought to be non-selective, just depending on the size of the molecules and allowing the passage of any ions or metabolites smaller than 1.2 kDa. 5 Recent developments in the field, however, have shown the selective permeability of gap junction channels formed by different connexins that are unique in terms of their conductance, gating and permeability to specific molecules. 6 For instance, Cx32 and Cx43 are well known to be expressed on oligodendroglia and astroglia, respectively, in the CNS, but their selective permeability for adenosine, adenosine monophosphate, adenosine diphosphate and adenosine triphosphate (ATP) are totally opposite. Cx32 has a 10-fold higher relative permeability to adenosine compared with Cx43, whereas Cx43 is eightfold more permeable to adenosine monophosphate and adenosine diphosphate, with more than 300-fold better permeability to ATP than Cx32.
Heterotypic channels formed by opposite gating polarity or voltage-dependent or independent hemichannels can rectify, and have a greater conductance in one direction than in the other. 1 Accordingly, the loss of one isoform cannot be compensated for by other isoforms that are expressed on the same cell, leading to pathophysiological deficits.
Nervous systems and connexins
Connexins in the peripheral nervous system Cx32 was identified in peripheral myelin, and Cx29 was also identified later in myelinating Schwann cells. Cx32 is thought to be important for the proliferation of Schwann cells during development, remyelination and nerve regeneration to distribute and synchronize signals important for proliferation and differentiation. Cx32 is expressed on non-compact myelin (paranodes) and Schmidt-Lanterman incisures. In addition, Cx32 is expressed in the regenerative nerve. The location of Cx32 expression indicates a radial diffusion pathway between adjacent layers of non-compacted myelin for signaling molecules, metabolites or ions from the inner (adaxonal) to the outer (abaxonal) cytoplasm. Cx29 is also expressed along the inner mesaxon, and at the inner paranodal and juxtaparanodal regions where Cx32 is not expressed. Interestingly, Cx29 does not form homomeric or heteromeric gap junctions with Cx32, indicating that Cx29 might function in non-junctional hemichannels. The function of Cx29 is still not clear, but is suggested to be a key regulator of K + buffering at these locations. 7 
Connexins in the CNS
Oligodendroglia in the CNS express Cx29, Cx32 and Cx47. 8 As indicated above, Cx29 works as a hemichannel. Cx32 and Cx47 are capable of composing homomeric gap junctions, but are unable to form heteromeric (Cx32-Cx47) gap junctions. Astroglia express Cx26, Cx30 and Cx43.
9 Cx26 and Cx30 form homomeric or heteromeric gap junctions, whereas Cx43 only forms homomeric gap junctions and never forms heteromeric coupling with Cx26 or Cx30. Astroglia-oligodendroglia gap junctions are composed predominantly of Cx43-Cx47, Cx30-Cx32 and Cx26-Cx32. This astroglial-astroglial and astroglial-oligodendroglial coupling is important for the propagation of Ca 2+ waves, transfer of metabolites and spatial buffering of increases in extracellular K + or neurotransmitters as a result of neuronal or synaptic activity. Neuronal expression of connexins in the CNS is rather restricted to Cx36 and Cx45. 10 Cx36 is most widely expressed in the mammalian brain, and composes homotypic gap junctions. Cx36 is assumed to contribute to electrical synapses in the CNS. Cx45 is also expressed in neurons similar to Cx36, and works as an electrical synapse. Heterotypic channels of Cx36 and Cx45 that make functional gap junctions have not been reported in any previous publications. As for neuron-glia interactions, several investigators have shown structural evidence for neuron-glia gap-junctions. 11, 12 However, recent examination using electron microscopic analysis failed to identify neuron-glia gap junctions. 13 Microglia, the third type of brain glial cell, are a major component of the innate immune system in the CNS. Connexin expression among microglia depends heavily on the context of their activation. In the resting state, Cx32 and Cx36 are expressed, and when they are activated the expression levels of Cx29, Cx32, Cx36 and Cx43 are elevated.
14 Neighboring microglial cells communicate with each other through Cx43 gap junctions, and other connexins and pannexin (Panx1) form hemichannels for the release of ATP and other cytokines, calcium ions, glutamate, and so on. In addition, microglia modulate connexin expression, and functional gap junction and hemichannel activity in astrocytes. Cx43 levels and dye coupling are reduced in astrocytes when co-cultured with microglia. Further investigation showed interleukin-1b and tumor necrosis factor-a from activated microglia are the main soluble factors affecting Cx43 expression on astroglia. 14 Watanabe et al. showed activated T cells reduce astroglial Cx43 expression through activation of microglia. 15 Another important "language" between astroglia and microglia is ATP. Astroglia release ATP through Cx43 hemichannels and Panx1, resulting in activation of purinergic receptors (e.g. P2XRs) on microglia. Activated microglia release glutamate thorough Cx43/Cx32 or Panx1 hemichannels, which leads to neuronal damage. 14 
Connexins and diseases
Heritable diseases caused by connexin gene mutations As heritable disorders, there are three major diseases known to be related to the mutation of connexin genes.
X-linked Charcot-Marie-Tooth disease (OMIM 302800)
Charcot-Marie-Tooth disease is a group of inherited peripheral nervous system diseases. Among them, X-linked Charcot-Marie-Tooth disease is due to mutation of Cx32. X-linked Charcot-Marie-Tooth disease is inherited in an X-linked manner, which means only males are affected. Usually there are mild or no symptoms in carrier females. The clinical course is characterized by slowly progressive sensorimotor neuropathy with subclinical abnormalities of visual and brainstem auditory evoked responses, CNS deficits including transient encephalopathy with abnormal white matter appearance on brain magnetic resonance imaging, corticospinal tract dysfunction or deafness. The cause is due to the failure of Schwann cells to provide metabolic or trophic support for normal axonal function. 16 Oculodentodigital dysplasia (OMIM 164200) Oculodentodigital dysplasia is an autosomal dominant syndrome due to Cx43 mutations. 17 It is defined by oculofacial abnormalities, syndactyly and hypoplastic tooth enamel. Characteristic facial appearances include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares, together with a narrow nasal bridge. 18 The teeth are usually small. Eyes show microphtalmia and microcornea. Sometimes, complete syndactyly of the fourth and fifth fingers occurs. Brain magnetic resonance imaging also shows hypointensity of the gray matter, and hyperintensity of the occipital and periventricular white matter.
Pelizaeus Merzbacher-like disease (OMIM 312080) Pelizaeus Merzbacher-like disease is an autosomal recessive disease associated with Cx47 deficits. 19 The clinical course of Pelizaeus Merzbacher-like disease is characterized by nystagmus, cerebellar ataxia and spasticity that occurs until 6 years-of-age. Magnetic resonance imaging examination usually reveals extensive white matter lesions with relative sparing of the corticospinal tracts. The loss of astroglial Cx43-oligodendroglial Cx47 gap junctions is assumed to be the cause of disease, but detailed pathogenicity still remains to be clarified.
Acquired CNS diseases related to functional modifications of connexins
Demyelinating/inflammatory disorders As connexins are robustly expressed by oligodendroglia and astroglia, expression levels and anatomical patterns vary during CNS demyelinating/ inflammatory disease lesions. 20 Masaki et al. reported that in acute progressive multiple sclerosis (MS) lesions, astroglial Cx43 is downregulated (known as "astrocytopathy"), which induces loss of astroglial-oligodendroglial connections and distal oligodendrogliopathy. 21 In contrast, oligodendroglial Cx32 and Cx47 are downregulated, whereas astroglial Cx30 and Cx43 are upregulated in chronic MS lesions, indicating that disconnection of oligodendroglia from astroglia might play roles in failed remyelination and disease progression. 22 An animal model of MS (experimental autoimmune encephalomyelitis [EAE] ) shows an aggravated disease course in oligodendroglial Cx32-deficient mice. As oligodendroglial Cx47 is known to be downregulated in the chronic MS lesion, we tested whether conditional oligodendroglial Cx47 deficiency could modulate EAE disease course. Using Cx47-PLP-Cre-ERT mice, we showed that oligodendroglial cell-specific Cx47 knockout aggravated EAE signs and increased relapse rate (unpubl. data). These findings indicate a protective function for oligodendroglial Cx47 in demyelinating lesions, possibly by promoting remyelination.
Astroglial Cx43 is known to be downregulated in acute MS lesions, so we examined modification of EAE clinical signs using Cx43-GLAST-Cre-ERT mice. In these mice, recombination of the Cx43 gene only occurs in brain grey matter and not in the spinal cord. Unexpectedly, these mice showed amelioration of EAE clinical signs (unpubl. data). As brain astroglial activation precedes the appearance of clinical signs, this might be due to the suppression of astroglial activation in the brains of the knockout mice, causing alleviation of EAE signs. 23 As astroglia also express Cx30, we analyzed if Cx30 deficiency also affects EAE clinical course. Surprisingly, even in the na€ ıve state, microglial activation was found in the CNS of Cx30-deficient mice. When EAE was induced in these mice, there were no obvious alterations of clinical signs in the acute phase, but they were ameliorated in the chronic stage of EAE (unpubl. data). Because microglia were activated in Cx30-deficient mice with milder EAE signs, we isolated microglia and carried out an RNA array assay. In the na€ ıve CX30-deficient microglia, genes related to Toll-like receptor and calcium channels were downregulated. These microglia tended not to deviate toward an "M1-like" phenotype, which is associated with proinflammatory activation. The reason why these microglia were activated is still unknown. Takeuchi et al. examined the expression patterns of connexin genes in CNS cells and showed Cx30 expression in microglia, indicating that both astroglial and microglial Cx30 synergistically modulate the EAE clinical course in Cx30-deficient mice. 24 The importance of this series of findings is that connexins play roles not only at the induction phase of EAE, but also in the chronic phase. Because there is no cure for the secondary-progressive phase of MS, connexins might become one of the targets for novel, disease-modifying therapies.
Seizures and epilepsy
Seizures result from pathological synchronous discharges of groups of neurons. Usually the propagation of abnormal discharges occurs through synaptic junctions, but some previous studies showed the importance of gap junctions. In slice cultures of Cx36-deficient mouse hippocampus, reduced 4-aminopyridine-induced seizure activity was found compared with slices from wild-type mice. 25 Oligodendroglial Cx32 deficiency leads to neuronal hyperexcitability, 26 and connexin channel blockers successfully showed anti-epileptic effects in both slice cultures and in vivo, indicating the importance of gap junctions in the mechanism of epileptogenicity. 27 Ischemia Ischemic brain injury induces robust activation of astroglia and microglia. A variety of agents that block gap junctions appear to be neuroprotective, whereas in genetic models, reduction or deletion of connexin expression leads to exacerbation of clinical signs. 28 The action of connexins in ischemia might relate to opening of hemichannels in the plasma membrane, thus contributing to ischemic damage through release of excitatory neurotransmitters, through disruption of cellular ionic gradients or loss of metabolites. 28 Carbenoxolone, one of the bestknown gap junction blockers, reduces lipid-peroxide formation; this might exert neuroprotective effects in ischemic lesions. 2 Motor neuron disease Neuronal synapses are comprised of metabolic synapses and electrical synapses. Cx36 is the main molecule for the development of electrical synapses. 29 We observed reduced expression levels of Cx36 in mutant Superoxide dismutase-1 (SOD1) transgenic mice (unpubl. data), a well-known mouse model of motor neuron disease. In addition, in mice, activation of microglia and astroglia is associated with elevated expression of gap junction hemichannels. 30 Takeuchi et al. successfully treated SOD1 mice with a gap junction/hemichannel blocker. 24 These findings clearly show the deleterious effects of hemichannels in motor neuron disease pathogenesis.
Alzheimer's disease In Alzheimer's disease (AD) patient brain samples, gap junction plaques and connexin expression were increased. These observations were confirmed in the amyloid precursor protein/presenilin 1 mouse model. Cx36 and Panx1 hemichannels are expressed on neurons and activated by the administration of amyloid Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] peptide in vitro. It is well known that irreversible opening of hemichannels exerts deleterious effects on neurons by inducing uncontrollable depolarization. As for astroglial connexins, both Cx43 and Cx30 expression levels are increased in astroglia around amyloid plaques in AD model mice and in human AD brain samples. In myloid precursor protein/presenilin 1/Cx43 fl/fl -GFAP/Cre mice, neuronal damage was reduced, indicating important roles for connexins in the pathogenesis of AD. 31 Major depressive disorders and autism spectrum disorders Although not many studies have suggested relationships between major depressive disorders/autism spectrum disorders (ASD) and gap junction dysfunctions, some studies have suggested pathomechanisms for each disorder involving connexins. In a functional study made in cortical and striatal mouse astroglia, antidepressants were shown to exert different effects on Cx43 gap junctions and hemichannel activities. These antidepressants inhibited Cx43 hemichannels. 32 Pro-inflammatory cytokines (tumor necrosis factor-a and interleukin-1b), which are released from activated microglia, open Cx43 hemichannels and this might be related to a major depressive disorders mechanism. 33 As for ASD, in post-mortem brain tissues of ASD patients, Cx43 expression was increased in the superior frontal cortex. 34 The contribution of the gut-brain axis has also been suggested as a pathomechanism of ASD; Cx43-expressing enteric glial cell dysfunction causes perturbation of gut microbiota, which leads to increased gut inflammation and causes neuronal dysfunctions. 35 
Conclusions
Connexins contribute to regulation of the normal and diseased CNS/peripheral nervous system milieu. Each pair of connexins exerts distinctive functions and are indispensable for the homeostasis of the human nervous system. Perturbation of the neuroglial network results in severe systemic dysfunctions, indicating the growing importance of scientific research in this field for the invention of novel therapeutic options.
